🇺🇸 FDA
Patent

US 9107832

Risperidone microparticles formed by sublimation

granted A61KA61K31/519A61K9/167

Quick answer

US patent 9107832 (Risperidone microparticles formed by sublimation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/519, A61K9/167, A61K9/1676, A61K9/1682